These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9892267)

  • 1. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.
    Kang ES; Tevlin MT; Wang YB; Chiang TM; Cardenas R; Myers LK; Acchiardo SR
    Am J Med Sci; 1999 Jan; 317(1):9-21. PubMed ID: 9892267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
    Kang ES; Miles DE; Tevlin MT; Cates TB; Acchiardo SR
    Am J Med Sci; 2001 Feb; 321(2):113-23. PubMed ID: 11217813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of asymmetric dimethylarginine to hemodialysis-associated hypotension in end-stage renal disease patients.
    Csiky B; Sulyok E; Lakatos O; Wittmann I; Martens-Lobenhoffer J; Bode-Boger SM
    Nephron Clin Pract; 2008; 108(2):c127-34. PubMed ID: 18230915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT; Böger RH; Bode-Böger SM; Schäffer J; Barbey M; Koch KM; Frölich JC
    J Am Soc Nephrol; 1999 Mar; 10(3):594-600. PubMed ID: 10073610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.
    Raj DS; Vincent B; Simpson K; Sato E; Jones KL; Welbourne TC; Levi M; Shah V; Blandon P; Zager P; Robbins RA
    Kidney Int; 2002 Feb; 61(2):697-704. PubMed ID: 11849413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric dimethylarginine is an independent predictor of intradialytic hypotension.
    Mangoni AA; Hewitson CL; Woodman RJ; Whiting MJ; McAteer-Carr B; Barbara JA
    Am J Hypertens; 2008 Aug; 21(8):955-9. PubMed ID: 18551101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease.
    Xiao S; Wagner L; Schmidt RJ; Baylis C
    Kidney Int; 2001 Apr; 59(4):1466-72. PubMed ID: 11260409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes.
    Schröder M; Riedel E; Beck W; Deppisch RM; Pommer W
    Kidney Int Suppl; 2001 Feb; 78():S19-24. PubMed ID: 11168977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine levels and nutritional status in hemodialysis patients.
    Cupisti A; Saba A; D'Alessandro C; Meola M; Panicucci E; Panichi V; Raffaelli A; Barsotti G
    J Nephrol; 2009; 22(5):623-9. PubMed ID: 19809995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indices of activity of the nitric oxide system in hemodialysis patients.
    Schmidt RJ; Domico J; Samsell LS; Yokota S; Tracy TS; Sorkin MI; Engels K; Baylis C
    Am J Kidney Dis; 1999 Aug; 34(2):228-34. PubMed ID: 10430967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differences of asymmetric dimethylarginine removal by different dialysis treatments.
    Zhang DL; Liu J; Liu S; Zhang Y; Liu WH
    Ren Fail; 2010; 32(8):935-40. PubMed ID: 20722560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum apelin-13 is positively correlated with ADMA in patients on maintenance hemodialysis.
    Zhang DL; Liao H; Wei YY; Zhang Y; Zhang QD; Wang ZG
    Clin Nephrol; 2009 Apr; 71(4):405-12. PubMed ID: 19356373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
    Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
    J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of asymmetric dimethylarginine to haemodialysis hypotension.
    Bergamini S; Vandelli L; Bellei E; Rota C; Manfredini P; Tomasi A; Albertazzi A; Iannone A
    Nitric Oxide; 2004 Nov; 11(3):273-8. PubMed ID: 15566974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nitric oxide on blood pressure in hemodialysis patients.
    Madore F; Prud'homme L; Austin JS; Blaise G; Francoeur M; Léveillé M; Prud'homme M; Vinay P
    Am J Kidney Dis; 1997 Nov; 30(5):665-71. PubMed ID: 9370182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between volume status and blood pressure during chronic hemodialysis.
    Leypoldt JK; Cheung AK; Delmez JA; Gassman JJ; Levin NW; Lewis JA; Lewis JL; Rocco MV
    Kidney Int; 2002 Jan; 61(1):266-75. PubMed ID: 11786109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
    Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
    Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.